
POET does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for POET and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for POET and 80,000+ other tickers.
See exactly how POET's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for POET and 80,000+ other tickers.
POET Technologies Inc., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products and services for commercial applications in the United States, Canada, Singapore, and China. The company offers photonic integrated packaging solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices onto a single chip using advanced wafer-level semiconductor manufacturing techniques. It also designs and develops photonic integrated circuits and optical engines based on the POET Optical…

TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced that it will exhibit at the 2026 China International Optoelectronic Expo (CIOE), taking place September 9-11, 2026, at the Shenzhen World Exhibition and Convention Center.

POET Technologies has experienced a 37% stock price decline, creating a healthier valuation and setting the stage for renewed upside. Following the pullback, POET now trades at a 15-month forward price-to-sales ratio of 13x, which I believe is justified by its robust revenue growth. The company recently delivered a double-beat earnings report with triple-digit percentage revenue growth, signaling potential sentiment turnaround.

A tiny photonics company just landed a massive purchase order from a hyperscaler supplier, and its balance sheet suddenly gives it years to prove whether that deal is the beginning of something enormous or just another false start.

Lumilens (POET's largest customer) raised $700 million at a $5.51 billion valuation while already supplying optical connectivity products to a major hyperscaler. POET secured an initial $50 million Lumilens order, potentially expanding beyond $500 million in cumulative purchases over five years. POET job openings surged 278% to 28 in July and reached 38 by August, signaling accelerating commercialization preparations.

Optical computing has become one of the most closely watched sub-themes in the AI infrastructure buildout, and few pure-plays sit closer to the bleeding edge than POET Technologies (NASDAQ:POET).